Pacer Advisors, Inc. Mirati Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$144.0 - $179.73 $58,752 - $73,329	-408 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$158.92 - $221.61 $23,202 - $32,355	-146 Reduced 26.35%	408 $70,000
Q4 2020 Jan 20, 2021	SELL	$162.05 - $240.27 $76,487 - $113,407	-472 Reduced 46.0%	554 $122,000
Q3 2020 Oct 19, 2020	BUY	$113.26 - $167.27 $116,204 - $171,619	1,026 New	1,026 $170,000
Q4 2018 Feb 13, 2019	SELL	$32.0 - $47.43 $119,296 - $176,819	-3,728 Closed	0 $0

Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $175,588 - $233,745	3,728 New	3,728 $176,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.